These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Nonalcoholic steatohepatitis: pathologic features and differential diagnosis. Brunt EM Semin Diagn Pathol; 2005 Nov; 22(4):330-8. PubMed ID: 16939061 [TBL] [Abstract][Full Text] [Related]
26. Hepatitis C infection and nonalcoholic fatty liver disease. Cheung O; Sanyal AJ Clin Liver Dis; 2008 Aug; 12(3):573-85, viii-ix. PubMed ID: 18625429 [TBL] [Abstract][Full Text] [Related]
27. Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: tools or decorations? Yilmaz Y; Dolar E World J Gastroenterol; 2009 Sep; 15(34):4346-7. PubMed ID: 19750583 [TBL] [Abstract][Full Text] [Related]
28. Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis. Chen C; Schmilovitz-Weiss H; Liu XE; Pappo O; Halpern M; Sulkes J; Braun M; Cohen M; Barak N; Tur-Kaspa R; Vanhooren V; Van Vlierberghe H; Libert C; Contreras R; Ben-Ari Z J Proteome Res; 2009 Feb; 8(2):463-70. PubMed ID: 19140676 [TBL] [Abstract][Full Text] [Related]
29. Severe steatohepatitis in a patient with a rare neutral lipid storage disorder due to ABHD5 mutation. Ronchetti A; Prati D; Pezzotta MG; Tavian D; Colombo R; Callea F; Colli A J Hepatol; 2008 Sep; 49(3):474-7. PubMed ID: 18644654 [TBL] [Abstract][Full Text] [Related]
30. Pancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis. Tanaka N; Horiuchi A; Yokoyama T; Kawa S; Kiyosawa K Am J Gastroenterol; 2008 Jan; 103(1):245-6. PubMed ID: 18184133 [No Abstract] [Full Text] [Related]
34. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Lazo M; Clark JM Semin Liver Dis; 2008 Nov; 28(4):339-50. PubMed ID: 18956290 [TBL] [Abstract][Full Text] [Related]
35. Uncovered issues in the overview of nonalcoholic steatohepatitis. Wang CC; Kao JH J Formos Med Assoc; 2011 Dec; 110(12):798. PubMed ID: 22248838 [No Abstract] [Full Text] [Related]
36. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis. Konopelska S; Kienitz T; Hughes B; Pirlich M; Bauditz J; Lochs H; Strasburger CJ; Stewart PM; Quinkler M Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910 [TBL] [Abstract][Full Text] [Related]
37. Keratin-18 as a marker of steatohepatitis. Gonzalez-Quintela A; Lojo S; Otero E; Perez LF Hepatology; 2007 Feb; 45(2):545. PubMed ID: 17256723 [No Abstract] [Full Text] [Related]
38. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Rubinstein E; Lavine JE; Schwimmer JB Semin Liver Dis; 2008 Nov; 28(4):380-5. PubMed ID: 18956294 [TBL] [Abstract][Full Text] [Related]